| Literature DB >> 33924886 |
Ying-Hsiang Chou1,2, Li-Hsiu Tai3,4, Chi-Ho Chan5, Haw-Yu Liu3,4, Han-Wei Yeh6, Yu-Hsun Wang7, Chiao-Wen Lin8, Shun-Fa Yang7,9, Ying-Cheng Chen9,10, Chao-Bin Yeh3,4,9.
Abstract
This study investigated the association between minor chest trauma and the risk of pneumonia among pediatric patients in a Taiwanese health care setting. For this retrospective population-based cohort study, the Longitudinal Health Insurance Database was used to analyze the data of patients with a minor chest injury between 2010 and 2012. Data were analyzed through a multivariate analysis with a multiple Cox regression model. Patients were divided into a chest trauma group (n = 6592) and a non-chest trauma group (n = 882,623). An increased risk of pneumonia was observed in the chest trauma group (hazard ratio = 1.23; 95% confidence interval = 1.02-1.49) compared to the non-chest trauma group. In conclusion, this population-based cohort study demonstrated that pediatric patients with minor chest trauma are at an increased risk of pneumonia. The short-term adverse effects of pneumonia could be severe when a patient suffers from mild chest trauma.Entities:
Keywords: minor chest trauma; pediatric patients; pneumonia
Year: 2021 PMID: 33924886 PMCID: PMC8124241 DOI: 10.3390/ijerph18094690
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart for patient selection.
Demographic data of study population of chest trauma and non-chest trauma.
| Variables | Chest Trauma | Non-Chest Trauma | |||
|---|---|---|---|---|---|
|
| % |
| % | ||
| Age on index date | 0.123 | ||||
| 0–5 | 412 | 11.4 | 1563 | 10.8 | |
| 6–11 | 1203 | 33.4 | 4626 | 32.1 | |
| 12–18 | 1989 | 55.2 | 8227 | 57.1 | |
| Mean ± SD | 12.03 ± 4.37 | 12.15 ± 4.34 | 0.141 | ||
| Gender | 0.798 | ||||
| Female | 1543 | 42.8 | 6138 | 42.6 | |
| Male | 2061 | 57.2 | 8278 | 57.4 | |
| Congenital anomalies | 44 | 1.2 | 223 | 1.5 | 0.147 |
| Cerebral palsy | 3 | 0.1 | 10 | 0.1 | 0.781 ¶ |
| Epilepsy | 15 | 0.4 | 38 | 0.3 | 0.130 |
| Asthma | 116 | 3.2 | 475 | 3.3 | 0.818 |
| Upper respiratory tract infection | 2929 | 81.3 | 11,619 | 80.6 | 0.360 |
| Atopic dermatitis | 100 | 2.8 | 468 | 3.2 | 0.147 |
| Allergic rhinitis | 937 | 26.0 | 3720 | 25.8 | 0.812 |
| NSAIDs | 2186 | 60.7 | 8563 | 59.4 | 0.169 |
| Track duration (years): mean ± SD | 0.98 ± 0.12 | 0.98 ± 0.11 | 0.012 | ||
† Statistic used chi-squared test or independent t test as appropriate. ¶ Fisher’s exact test.
Figure 2Kaplan–Meier curves of the cumulative proportion of pneumonia.
Cox proportional hazard model of pneumonia event.
| Variables | No. of Subjects | No. of Pneumonia Event | Crude HR | 95% C.I. | Adjusted HR † | 95% C.I. | ||
|---|---|---|---|---|---|---|---|---|
| Group | ||||||||
| Non-chest trauma | 14,416 | 437 | 1 | 1 | ||||
| Chest trauma | 3604 | 137 | 1.26 | 1.04–1.53 | 0.018 | 1.23 | 1.02–1.49 | 0.034 |
| Age on index date | ||||||||
| 0–5 | 1975 | 248 | 1 | 1 | ||||
| 6–11 | 5829 | 193 | 0.25 | 0.21–0.30 | <0.001 | 0.26 | 0.21–0.31 | <0.001 |
| 12–18 | 10,216 | 133 | 0.10 | 0.08–0.12 | <0.001 | 0.11 | 0.08–0.13 | <0.001 |
| Gender | ||||||||
| Female | 7681 | 254 | 1 | 1 | ||||
| Male | 10,339 | 320 | 0.94 | 0.79–1.10 | 0.436 | 1.04 | 0.88–1.23 | 0.622 |
| Congenital anomalies | 267 | 16 | 1.95 | 1.18–3.20 | 0.009 | 1.76 | 1.07–2.91 | 0.026 |
| Epilepsy | 53 | 6 | 3.73 | 1.67–8.33 | 0.001 | 4.95 | 2.21–11.10 | <0.001 |
| Asthma | 591 | 39 | 2.20 | 1.59–3.04 | <0.001 | 1.26 | 0.90–1.75 | 0.172 |
| Upper respiratory tract infection | 14,548 | 534 | 3.23 | 2.34–4.45 | <0.001 | 1.77 | 1.27–2.47 | <0.001 |
| Atopic dermatitis | 568 | 41 | 2.41 | 1.75–3.31 | <0.001 | 0.95 | 0.68–1.31 | 0.741 |
| Allergic rhinitis | 4657 | 159 | 1.10 | 0.92–1.32 | 0.299 | 1.31 | 1.08–1.59 | 0.005 |
| NSAIDs | 10,749 | 406 | 1.64 | 1.37–1.96 | <0.001 | 1.09 | 0.90–1.32 | 0.363 |
† Adjusted for age, gender, congenital anomalies, epilepsy, asthma, upper respiratory tract infection, atopic dermatitis, allergic rhinitis, and NSAIDs.
Subgroup analysis of Cox proportional hazard model of pneumonia event.
| Variables | Chest Trauma | Non-Chest Trauma | HR | 95% CI | |||
|---|---|---|---|---|---|---|---|
|
| No. of Pneumonia Event |
| No. of Pneumonia Event | ||||
| Age | |||||||
| 0–5 | 412 | 60 | 1563 | 188 | 1.24 | 0.93–1.66 | 0.149 |
| 6–11 | 1203 | 42 | 4626 | 151 | 1.07 | 0.76–1.51 | 0.690 |
| 12–18 | 1989 | 35 | 8227 | 98 | 1.48 | 1.01–2.18 | 0.046 |
| Gender | |||||||
| Female | 1543 | 65 | 6138 | 189 | 1.38 | 1.04–1.83 | 0.026 |
| Male | 2061 | 72 | 8278 | 248 | 1.17 | 0.90–1.52 | 0.238 |
| Congenital anomalies | |||||||
| No | 3560 | 135 | 14,193 | 423 | 1.28 | 1.05–1.55 | 0.013 |
| Yes | 44 | 2 | 223 | 14 | 0.71 | 0.16–3.14 | 0.654 |
| Epilepsy | |||||||
| No | 3589 | 136 | 14,378 | 432 | 1.27 | 1.05–1.54 | 0.016 |
| Yes | 15 | 1 | 38 | 5 | 0.48 | 0.06–4.11 | 0.503 |
| Asthma | |||||||
| No | 3488 | 132 | 13,941 | 403 | 1.32 | 1.08–1.60 | 0.006 |
| Yes | 116 | 5 | 475 | 34 | 0.59 | 0.23–1.52 | 0.276 |
| Upper respiratory tract infection | |||||||
| No | 675 | 9 | 2797 | 31 | 1.20 | 0.57–2.52 | 0.632 |
| Yes | 2929 | 128 | 11,619 | 406 | 1.26 | 1.03–1.54 | 0.023 |
| Atopic dermatitis | |||||||
| No | 3504 | 126 | 13,948 | 407 | 1.24 | 1.01–1.51 | 0.036 |
| Yes | 100 | 11 | 468 | 30 | 1.77 | 0.88–3.52 | 0.107 |
| Allergic rhinitis | |||||||
| No | 2667 | 93 | 10,696 | 322 | 1.16 | 0.92–1.47 | 0.197 |
| Yes | 937 | 44 | 3720 | 115 | 1.53 | 1.08–2.17 | 0.016 |
| NSAIDs | |||||||
| No | 1418 | 46 | 5853 | 122 | 1.57 | 1.12–2.20 | 0.009 |
| Yes | 2186 | 91 | 8563 | 315 | 1.14 | 0.90–1.43 | 0.285 |
Sensitivity analysis for the follow up duration of pneumonia event.
| Variables | No. of Subjects | No. of Pneumonia Event | Crude HR | 95% C.I. | Adjusted HR † | 95% C.I. | ||
|---|---|---|---|---|---|---|---|---|
| Follow-up duration ≤1 months | ||||||||
| Group | ||||||||
| Non-chest trauma | 14,416 | 50 | 1 | 1 | ||||
| Chest trauma | 3604 | 12 | 0.96 | 0.51–1.80 | 0.900 | 0.92 | 0.49–1.73 | 0.801 |
| Follow-up duration ≤3 months | ||||||||
| Group | ||||||||
| Non-chest trauma | 14,416 | 118 | 1 | 1 | ||||
| Chest trauma | 3604 | 43 | 1.46 | 1.03–2.07 | 0.034 | 1.42 | 1.00–2.01 | 0.049 |
| Follow-up duration ≤6 months | ||||||||
| Group | ||||||||
| Non-chest trauma | 14,416 | 238 | 1 | 1 | ||||
| Chest trauma | 3604 | 80 | 1.35 | 1.05–1.74 | 0.020 | 1.33 | 1.03–1.71 | 0.028 |
† Adjusted for age, gender, congenital anomalies, epilepsy, asthma, upper respiratory tract infection, atopic dermatitis, allergic rhinitis, and NSAIDs.